Brim Biotechnology Inc.
Clinical trials sponsored by Brim Biotechnology Inc., explained in plain language.
-
New eye drops aim to soothe dry, irritated eyes
Symptom relief CompletedThis study tested whether BRM421 eye drops can safely reduce the signs and symptoms of dry eye compared to a placebo. 157 adults with dry eye for at least 6 months participated. Researchers measured changes in eye surface staining and discomfort scores in a controlled dry environ…
Phase: PHASE2 • Sponsor: BRIM Biotechnology Inc. • Aim: Symptom relief
Last updated May 26, 2026 08:53 UTC
-
New eye drops aim to soothe dry eye in just two weeks
Symptom relief CompletedThis study tested whether BRM421 eye drops can safely relieve dry eye symptoms better than a placebo. About 220 adults with dry eye for at least 6 months used the drops or a placebo for 14 days. Researchers measured changes in eye surface damage and dryness scores to see if the t…
Phase: PHASE2, PHASE3 • Sponsor: BRIM Biotechnology Inc. • Aim: Symptom relief
Last updated May 11, 2026 20:53 UTC